SK492001A3 - Biphenyl derivatives - Google Patents
Biphenyl derivatives Download PDFInfo
- Publication number
- SK492001A3 SK492001A3 SK49-2001A SK492001A SK492001A3 SK 492001 A3 SK492001 A3 SK 492001A3 SK 492001 A SK492001 A SK 492001A SK 492001 A3 SK492001 A3 SK 492001A3
- Authority
- SK
- Slovakia
- Prior art keywords
- methyl
- group
- formula
- phenyl
- methoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Psychology (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98113488 | 1998-07-20 | ||
| PCT/EP1999/004803 WO2000005225A1 (fr) | 1998-07-20 | 1999-07-08 | Derives de biphenyle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK492001A3 true SK492001A3 (en) | 2001-08-06 |
Family
ID=8232308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK49-2001A SK492001A3 (en) | 1998-07-20 | 1999-07-08 | Biphenyl derivatives |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1098892A1 (fr) |
| JP (1) | JP2002521377A (fr) |
| KR (1) | KR20010070997A (fr) |
| CN (1) | CN1309654A (fr) |
| AR (1) | AR019415A1 (fr) |
| AU (1) | AU5033899A (fr) |
| BR (1) | BR9912299A (fr) |
| CA (1) | CA2338209A1 (fr) |
| HU (1) | HUP0102622A3 (fr) |
| ID (1) | ID27846A (fr) |
| NO (1) | NO20010333L (fr) |
| PL (1) | PL345283A1 (fr) |
| SK (1) | SK492001A3 (fr) |
| WO (1) | WO2000005225A1 (fr) |
| ZA (1) | ZA200101379B (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60131675T2 (de) * | 2000-11-14 | 2008-11-20 | Merck Patent Gmbh | Neue verwendung von substanzen mit kombinierten 5-ht1a agonistischen und serotonin reuptake inhibitor-aktivitäten |
| JP4092203B2 (ja) | 2000-12-21 | 2008-05-28 | ニトロメッド，インク． | 新規のシクロオキシゲナーゼ２選択的阻害剤としての置換アリール化合物、組成物、および使用方法 |
| EP1406884A1 (fr) | 2001-05-11 | 2004-04-14 | Biovitrum Ab | Composes arylsulfonamide pour le traitement de l'obesite, de diabetes de type ii et de troubles du systeme nerveux central |
| US7718650B2 (en) | 2001-05-11 | 2010-05-18 | Biovitrum Ab | Aryl sulfonamide compounds for treating obesity |
| AU2002327627B2 (en) | 2001-09-14 | 2006-09-14 | Methylgene Inc. | Inhibitors of histone deacetylase |
| SE0103644D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic isoquinoline compounds |
| BRPI0513713A (pt) | 2004-07-28 | 2008-05-13 | Glaxo Group Ltd | derivados de piperazina úteis para o tratamento de distúrbios gastrointestinais |
| ES2364488T3 (es) * | 2004-10-14 | 2011-09-05 | ABBOTT GMBH & CO. KG | Compuestos heterocíclicos adecuados para el tratamiento de trastornos que responden a la modulación del receptor de dopamina. |
| WO2007077457A2 (fr) * | 2006-01-06 | 2007-07-12 | The Royal Veterinary College | Traitement de la fourbure chez le cheval |
| EP2013178A1 (fr) | 2006-03-31 | 2009-01-14 | Glaxo Group Limited | Dérivés de pipérazine utilisés comme agonistes du récepteur du sécrétagogue de l'hormone de croissance (shc) |
| AU2007239494A1 (en) * | 2006-04-19 | 2007-10-25 | Abbott Gmbh & Co. Kg | Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
| EP2074110A1 (fr) | 2006-04-19 | 2009-07-01 | Abbott GmbH & Co. KG | Composés hétérocycliques pouvant être utilisés pour traiter des troubles qui répondent à la modulation du récepteur de sérotonine 5ht6 |
| CN101432261A (zh) | 2006-05-19 | 2009-05-13 | 惠氏公司 | 作为组织胺-3拮抗剂的n-苯甲酰基-吡咯烷-3-基胺和n-苄基-吡咯烷-3-基胺 |
| KR20090123977A (ko) | 2007-03-23 | 2009-12-02 | 애보트 게엠베하 운트 콤파니 카게 | 세로토닌 5-ｈｔ6 수용체의 조절에 반응하는 장애를 치료하는데 적합한 아제티딘 화합물 |
| CA2690091A1 (fr) | 2007-06-05 | 2008-12-11 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Nouvelles phenylpyrrolidines disubstituees en tant que modulateurs de la neurotransmission catecholaminergique corticale |
| ES2558152T3 (es) | 2007-06-08 | 2016-02-02 | Janssen Pharmaceutica, N.V. | Derivados de piperidina/piperazina |
| ES2483898T3 (es) | 2007-06-08 | 2014-08-08 | Janssen Pharmaceutica, N.V. | Derivados de piperidina/piperazina |
| JO2972B1 (en) | 2007-06-08 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Piperidine / piperazine derivatives |
| CA2687754C (fr) | 2007-06-08 | 2015-12-08 | Janssen Pharmaceutica N.V. | Derives de piperidine/piperazine pour utilisation en tant qu'inhibiteurs de dgat |
| PE20140572A1 (es) | 2008-06-05 | 2014-05-16 | Janssen Pharmaceutica Nv | Combinaciones de drogas que comprenden un inhibidor de dgat y un agonista de ppar |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9119920D0 (en) * | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
| DE69232003T2 (de) * | 1991-09-18 | 2002-04-25 | Glaxo Group Ltd., Greenford | Benzanilidderivate als 5-HT1D-Antagonisten |
| GB2273930A (en) * | 1992-12-30 | 1994-07-06 | Glaxo Group Ltd | Benzanilide derivatives |
| GB9507203D0 (en) * | 1995-04-07 | 1995-05-31 | Smithkline Beecham Plc | Novel compounds |
-
1999
- 1999-07-08 AU AU50338/99A patent/AU5033899A/en not_active Abandoned
- 1999-07-08 JP JP2000561181A patent/JP2002521377A/ja active Pending
- 1999-07-08 PL PL99345283A patent/PL345283A1/xx unknown
- 1999-07-08 SK SK49-2001A patent/SK492001A3/sk unknown
- 1999-07-08 CN CN99808739A patent/CN1309654A/zh active Pending
- 1999-07-08 ID IDW20010307A patent/ID27846A/id unknown
- 1999-07-08 CA CA002338209A patent/CA2338209A1/fr not_active Abandoned
- 1999-07-08 KR KR1020017000849A patent/KR20010070997A/ko not_active Application Discontinuation
- 1999-07-08 BR BR9912299-5A patent/BR9912299A/pt not_active Application Discontinuation
- 1999-07-08 WO PCT/EP1999/004803 patent/WO2000005225A1/fr not_active Application Discontinuation
- 1999-07-08 EP EP99934632A patent/EP1098892A1/fr not_active Withdrawn
- 1999-07-08 HU HU0102622A patent/HUP0102622A3/hu unknown
- 1999-07-16 AR ARP990103510A patent/AR019415A1/es not_active Application Discontinuation
-
2001
- 2001-01-19 NO NO20010333A patent/NO20010333L/no unknown
- 2001-02-19 ZA ZA200101379A patent/ZA200101379B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200101379B (en) | 2002-05-20 |
| EP1098892A1 (fr) | 2001-05-16 |
| HUP0102622A3 (en) | 2002-12-28 |
| CN1309654A (zh) | 2001-08-22 |
| KR20010070997A (ko) | 2001-07-28 |
| NO20010333D0 (no) | 2001-01-19 |
| AU5033899A (en) | 2000-02-14 |
| NO20010333L (no) | 2001-01-19 |
| ID27846A (id) | 2001-04-26 |
| JP2002521377A (ja) | 2002-07-16 |
| WO2000005225A1 (fr) | 2000-02-03 |
| BR9912299A (pt) | 2001-11-20 |
| PL345283A1 (en) | 2001-12-03 |
| CA2338209A1 (fr) | 2000-02-03 |
| AR019415A1 (es) | 2002-02-20 |
| HUP0102622A2 (hu) | 2001-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK492001A3 (en) | Biphenyl derivatives | |
| AU2005209441B2 (en) | Derivatives of N-` (1,5-diphenyl-1H-pyrazol-3-yl) sulphonamide with CB1 receptor affinity | |
| JP4795889B2 (ja) | ベンゾフラン化合物 | |
| JP2009520811A (ja) | プロテインキナーゼ活性を阻害するアミノピリミジン誘導体、及びその製造方法並びにこれを有効成分として含む医薬組成物 | |
| US20040242589A1 (en) | 3-arylsulfonyl-7-piperzinyl-indoles-benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders | |
| SK282799B6 (sk) | Derivát benzamidínu ako inhibítor faktora XA, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje | |
| TWI313266B (en) | Thiazoline derivatives and pharmaceutical composition containing the same | |
| US20090012134A1 (en) | Arylsulfonyl Benzofused Heterocycles as 5-Ht2a Antagonists | |
| WO2004096771A1 (fr) | Composes biaryle exerçant une activite sur le recepteur de 5ht5a | |
| US5726177A (en) | Indole-derived arylpiperazines as ligands for 5HT1 -like, 5HT1B and 5HT1D receptors | |
| TW201323419A (zh) | 經胺基烷基取代之ｎ－噻吩基苯甲醯胺衍生物 | |
| JP4202438B2 (ja) | 接着性レセプター拮抗化合物 | |
| CA2588768A1 (fr) | Derives d'amides aromatiques, compositions medicinales contenant ces derniers et utilisations medicales de ces deux elements | |
| JP2013534229A (ja) | バニロイド受容体リガンドとしての置換された環状カルボキサミド誘導体および尿素誘導体 | |
| US7566709B2 (en) | 1,3,4-Substituted pyrazoles as 5-HT receptor antagonists for the treatment of psychoses and neurological disorders | |
| CA2194481A1 (fr) | Derives de 2-ureido-benzamide | |
| SK9232001A3 (en) | Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands | |
| US20060122191A1 (en) | N-(indolethyl-)cycloamine compounds | |
| SK112799A3 (en) | Oxazolidinones, preparation method and use thereof, pharmaceutical compositions | |
| KR20050119195A (ko) | 피라졸 화합물 | |
| JP2006527707A (ja) | セロトニン再取り込み阻害剤としてのインドール誘導体 | |
| WO1993021179A1 (fr) | Nouvelle piperazine d'aminoalkyle et d'iminoalkyle | |
| JP2002509135A (ja) | 神経細胞カルシウムチャンネルの活性の調節剤としてのアミノスルホニルベンズアミド誘導体 | |
| US20050282819A1 (en) | Heterocyclic substituted indane derivatives and related compounds for the treatment of schizophrenia | |
| JP2007513197A6 (ja) | 統合失調症の治療のための複素環式置換インダン誘導体および関連化合物 |